COMP <GO>
NSPR vs PMI // 10Y YIELD & FRED MACRO BETA
InspireMD Inc. (NASDAQ) VS. Picard Medical Inc. (NYSE) • 15-METRIC TALLY: NSPR 1
— PMI 1
■ METRIC PARITY
LAST: $0.45 (-3.55%) • MKT CAP: $21.0M
macro-sensitivity
—
LAST: $8.11 (+12.17%) • MKT CAP: $19.9M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NSPR VS. PMI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NSPR | PMI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 28.10% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.2 | 50.2 | -20.00 | PMI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.0M | $19.9M | $1.0M | NSPR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NSPR REV | PMI REV | NSPR GROSS % | PMI GROSS % | NSPR FCF | PMI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.0M | $0 | 29.5% | — | -$36.8M | — |
| FY 2024 | $7.0M | — | 21.5% | — | -$23.3M | — |
| FY 2023 | $6.2M | — | — | — | -$16.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NSPR // BETA —
PMI // BETA —